USPTOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The US trademark ALBREC was filed as Word mark on 08/18/2000 at the U.S. Patent and Trademark Office.
It was registered as a trademark on 11/25/2003.
The current status of the mark is "CANCELLED - SECTION 8".
| Trademark form | Word mark |
| File reference | 76113334 |
| Register number | 2785302 |
| Application date | August 18, 2000 |
| Publication date | September 2, 2003 |
| Entry date | November 25, 2003 |
Trademark owner
Chuo-ku, Osaka-shi
Osaka
JP
Osaka
JP
Trademark representatives
goods and services
5
Pharmaceutical preparations in the nature of recombinant human albuminous preparations for the treatment of hypovolemic shock, adult respiratory distress syndrome, major injury or surgery resulting in increased albumin loss or inadequate synthesis, acute nephrosis not responding to cyclophosphamide or steroid therapy, and acute liver failure or ascites where the therapeutic use is regulated by the individual circumstances; pharmaceutical preparations in the nature of recombinant human albuminous preparations as an adjunct in hemodialysis for patients undergoing long-term dialysis or for those patients who are fluid-overloaded and cannot tolerate substantial volumes of salt solution for therapy of shock or hypertension; pharmaceutical preparations in the nature of recombinant human albuminous preparations for the treatment of cardiac disease in cardiopulmonary bypass procedures; pharmaceutical preparations in the nature of recombinant human albuminous preparations in conjunction with exchange transfusion in the treatment of neonatal hyperbilirubinemia; pharmaceutical preparations in the nature of recombinant human albuminous preparations for use in the treatment of conditions in which there is severe hypoalbuminemia
ID: 1376113334